Ribonucleic Acid (RNA) Probe Market Report 2026
Global Outlook – By Product Type (Labeled Ribonucleic Acid Probes, Radiolabeled Ribonucleic Acid Probes, Biotinylated Ribonucleic Acid Probes, Digoxigenin Labeled Ribonucleic Acid Probes, Chemiluminescent Ribonucleic Acid Probes, Custom Or Synthesized Ribonucleic Acid Probes), By Technology (In Situ Hybridization, Fluorescence In Situ Hybridization, Polymerase Chain Reaction, Next Generation Sequencing), By Delivery Method (Microinjection, Nanoliposomal Delivery, Viral Vectors, Electroporation), By Application (Gene Expression Studies, Molecular Diagnostics, Drug Discovery And Development, Cancer Research), By End User (Biotechnology Companies, Pharmaceutical Companies, Academic And Research Institutes, Diagnostic Laboratories, Contract Research Organizations) – Market Size, Trends, Strategies, and Forecast to 2030
Ribonucleic Acid (RNA) Probe Market Report 2026 Market Overview
• Ribonucleic Acid (RNA) Probe Market Report 2026 market size has reached to $1.91 billion in 2025 • Expected to grow to $2.92 billion in 2030 at a compound annual growth rate (CAGR) of 8.8% • Growth Driver: Rising Prevalence Of Genetic Disorders Driving The Market Growth Due To Increasing Demand For Advanced Genomic Analysis • Market Trend: Innovation In High-Fidelity RNA Synthesis Systems Enhancing Accuracy And Efficiency In RNA Probe Development • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Ribonucleic Acid (RNA) Probe Market?
Ribonucleic acid (RNA) probes refer to short, single-stranded RNA molecules that are designed to bind selectively to complementary nucleic acid sequences for the purpose of detecting, identifying, or quantifying specific RNA targets. These probes are engineered using precise nucleotide sequences and are often labeled with fluorescent, radioactive, or enzymatic markers to enable visualization and analysis. They are widely used in molecular diagnostics and research workflows to support gene expression analysis, pathogen detection, and genetic characterization with high specificity and sensitivity. The main product types of ribonucleic acid (RNA) probe include labeled ribonucleic acid probes, radiolabeled ribonucleic acid probes, biotinylated ribonucleic acid probes, digoxigenin labeled ribonucleic acid probes, chemiluminescent ribonucleic acid probes, and custom or synthesized ribonucleic acid probes. Labeled ribonucleic acid probes refer to RNA molecules tagged with detectable markers used for identifying and analyzing specific nucleic acid sequences. These products use technologies such as in situ hybridization, fluorescence in situ hybridization, polymerase chain reaction, and next generation sequencing and are delivered through microinjection, nanoliposomal delivery, viral vectors, and electroporation. The key applications of gene expression studies, molecular diagnostics, drug discovery and development, and cancer research, while the end-users biotechnology companies, pharmaceutical companies, academic and research institutes, diagnostic laboratories, and contract research organizations.
What Is The Ribonucleic Acid (RNA) Probe Market Size and Share 2026?
The ribonucleic acid (RNA) probe market size has grown strongly in recent years. It will grow from $1.91 billion in 2025 to $2.08 billion in 2026 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to growth in molecular diagnostics and gene expression research, development of fluorescent and radiolabeled probe technologies, increasing adoption of in situ hybridization techniques, expansion of cancer genomics and infectious disease testing, rising demand for high specificity nucleic acid detection methods.What Is The Ribonucleic Acid (RNA) Probe Market Growth Forecast?
The ribonucleic acid (RNA) probe market size is expected to see strong growth in the next few years. It will grow to $2.92 billion in 2030 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to integration of AI driven probe design and sequence optimization tools, increasing demand for precision diagnostics and personalized medicine, expansion of spatial transcriptomics and single cell analysis applications, rising adoption of multiplexed and high throughput probe based assays, growth in advanced imaging and molecular detection technologies. Major trends in the forecast period include integration of fluorescent multiplex rna probe technologies for high sensitivity gene expression detection, increasing adoption of custom synthesized rna probes for precision molecular diagnostics, growing use of isothermal amplification based probe detection systems, expansion of in situ hybridization techniques for spatial transcriptomics, rising demand for enzyme labeled probes in cancer and pathogen detection workflows.
Global Ribonucleic Acid (RNA) Probe Market Segmentation
1) By Product Type: Labeled Ribonucleic Acid Probes, Radiolabeled Ribonucleic Acid Probes, Biotinylated Ribonucleic Acid Probes, Digoxigenin Labeled Ribonucleic Acid Probes, Chemiluminescent Ribonucleic Acid Probes, Custom Or Synthesized Ribonucleic Acid Probes 2) By Technology: In Situ Hybridization, Fluorescence In Situ Hybridization, Polymerase Chain Reaction, Next Generation Sequencing 3) By Delivery Method: Microinjection, Nanoliposomal Delivery, Viral Vectors, Electroporation 4) By Application: Gene Expression Studies, Molecular Diagnostics, Drug Discovery And Development, Cancer Research 5) By End User: Biotechnology Companies, Pharmaceutical Companies, Academic And Research Institutes, Diagnostic Laboratories, Contract Research Organizations Subsegments: 1) By Labeled Ribonucleic Acid Probes: Fluorescent Labeled Ribonucleic Acid Probes, Enzyme Labeled Ribonucleic Acid Probes, Hapten Labeled Ribonucleic Acid Probes, Radioisotope Labeled Ribonucleic Acid Probes, Multiplex Or Dual Labeled Ribonucleic Acid Probes 2) By Radiolabeled Ribonucleic Acid Probes: Phosphorus Thirty Two Labeled Probes, Sulfur Thirty Five Labeled Probes, Tritium Labeled Probes, Iodine One Hundred Twenty Five Labeled Probes, Single End Or Internally Radiolabeled Probes 3) By Biotinylated Ribonucleic Acid Probes: Single Biotin Labeled Probes, Multiple Biotin Labeled Probes, Terminal Biotin Labeled Probes, Internal Biotin Labeled Probes, Streptavidin Based Detection Format Probes 4) By Digoxigenin Labeled Ribonucleic Acid Probes: Single Digoxigenin Labeled Probes, Dual Digoxigenin Labeled Probes, Terminal Digoxigenin Modified Probes, Internal Digoxigenin Incorporated Probes, Anti Digoxigenin Antibody Detection Based Probes 5) By Chemiluminescent Ribonucleic Acid Probes: Horseradish Peroxidase Based Chemiluminescent Probes, Alkaline Phosphatase Based Probes, Luminol Based Detection Probes, Chlorophenolred Beta D Galactopyranoside Or Chlorophenolred Beta D Galactopyranoside Star Substrate Based Probes, Direct Or Amplified Chemiluminescent Signal Probes 6) By Custom Or Synthesized Ribonucleic Acid Probes: In Vitro Transcription Derived Ribonucleic Acid Probes, Synthetic Oligonucleotide Ribonucleic Acid Probes, Polymerase Chain Reaction Generated Ribonucleic Acid Probes, Full Length Or Fragment Ribonucleic Acid Probes, Application Specific ProbesWhat Is The Driver Of The Ribonucleic Acid (RNA) Probe Market?
The rising prevalence of genetic disorders is expected to propel the growth of the ribonucleic acid (RNA) probe market going forward. Genetic disorders refer to diseases or conditions caused by changes or mutations in an individual’s DNA, which can be inherited from parents or occur spontaneously. The prevalence of genetic disorders is growing due to improving diagnostic technologies and expanding genetic screening programs, which allow more cases to be identified that previously went undetected. Ribonucleic acid (RNA) probes enable the detection of genetic disorders by binding specifically to complementary messenger RNA sequences to identify abnormal gene expression and genetic mutations for accurate molecular diagnosis. For instance, in October 2025, according to the Cystic Fibrosis Trust, a UK-based charity dedicated to supporting people with cystic fibrosis, cystic fibrosis patient registrations increased from 11,148 in 2022 and 11,318 in 2023 to 11,381 in 2024, reflecting continued year-over-year growth. Therefore, the rising prevalence of genetic disorders is driving the growth of the ribonucleic acid (RNA) probe industry.Key Players In The Global Ribonucleic Acid (RNA) Probe Market
Major companies operating in the ribonucleic acid (RNA) probe market report are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Eurofins Scientific SE, Agilent Technologies Inc., Revvity Inc., QIAGEN N.V., Bio-Techne Corporation, GenScript Biotech Corporation, Takara Bio Inc., RiboBio Co. Ltd., Bio-Synthesis Inc., Biotage AB, Biolegio B.V., Ella Biotech GmbH, Baseclick GmbH, Geno Technology Inc., Enzo Biochem Inc., LGC Biosearch Technologies, Integrated DNA Technologies (IDT)
This chart is for illustrative purposes; the full report includes a detailed competitor analysis and comprehensive overview of the top 10 companies in the market.
This chart maps companies by product innovation and brand strength, with bubble size indicating relative revenue, helping identify market leaders, challengers, and niche players. This is an illustrative chart; the full report provides a complete and accurate competitive analysis.
Explore how leading companies compare across key metrics in our report Get Report
Global Ribonucleic Acid (RNA) Probe Market Trends and Insights
Major companies operating in the ribonucleic acid (RNA) Probe market are focusing on developing innovative solutions, such as high-fidelity RNA synthesis enzymes to enhance probe quality, reduce immunogenic byproducts, and improve accuracy in molecular diagnostics and research applications. High-fidelity RNA synthesis systems are advanced molecular biology tools designed to generate RNA molecules with improved purity and reduced double-stranded RNA (dsRNA) contamination, which can otherwise trigger unwanted immune responses and reduce assay reliability compared to conventional RNA polymerase-based synthesis methods. For instance, in September 2024, TriLink BioTechnologies Inc., a US-based Maravai LifeSciences company, in collaboration with Alphazyme LLC, a US-based biotechnology company, launched CleanScribe RNA Polymerase, a novel enzyme designed to significantly improve RNA synthesis quality. The enzyme reduces double-stranded RNA formation by up to 85% during in vitro transcription, enhancing the safety and effectiveness of RNA-based applications including RNA probe preparation and mRNA construct development. Additionally, the system integrates seamlessly into existing IVT workflows without requiring major protocol changes, making it suitable for both research and therapeutic RNA production pipelines. The technology supports improved reproducibility and higher-quality RNA outputs, contributing to more reliable downstream diagnostic and genomic applications.What Are Latest Mergers And Acquisitions In The Ribonucleic Acid (RNA) Probe Market?
In May 2024, Bruker Corporation, a US-based technology company, acquired the NanoString Technologies Inc. business for $392.6 million. With this acquisition, Bruker aimed to strengthen its spatial biology and life sciences tools portfolio by integrating NanoString’s gene expression profiling and spatial transcriptomics platforms, thereby expanding its capabilities in advanced biological research, translational science, and multi-omics discovery workflows across academic and clinical research markets. NanoString Technologies Inc. is a US-based life sciences tools company that specializes in providing target-specific hybridization probes to detect and quantify Ribonucleic Acid (RNA).
Regional Outlook
North America was the largest region in the ribonucleic acid (RNA) probe market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.Need data for a specific geography? Request Regional Data
What Defines the Ribonucleic Acid (RNA) Probe Market?
The ribonucleic acid (RNA) probe market consists of sales of fluorescent RNA probes, gene expression detection probes, and pathogen detection RNA probes. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This chart presents market attractiveness based on a quantitative evaluation of growth, competition, strategic alignment, and risk, offering a clear view of opportunity areas for decision-making. This chart is for illustrative purposes; the full report contains the complete analysis.
This chart highlights the Total Addressable Market (TAM) by estimating the maximum revenue opportunity using an assumption-driven approach, supporting strategic planning and opportunity sizing across markets. The chart is illustrative; the full report provides a more comprehensive analysis.
Access full TAM calculations and growth projections in our report Get Report
What Key Data and Analysis Are Included in the Ribonucleic Acid (RNA) Probe Market Report 2026?
The ribonucleic acid (rna) probe market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the ribonucleic acid (rna) probe industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Ribonucleic Acid (RNA) Probe Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $2.08 billion |
| Revenue Forecast In 2030 | $2.92 billion |
| Growth Rate | CAGR of 8.8% from 2026 to 2030 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2030 |
| Segments Covered | Product Type, Technology, Delivery Method, Application, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. |
| Key Companies Profiled | F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Eurofins Scientific SE, Agilent Technologies Inc., Revvity Inc., QIAGEN N.V., Bio-Techne Corporation, GenScript Biotech Corporation, Takara Bio Inc., RiboBio Co. Ltd., Bio-Synthesis Inc., Biotage AB, Biolegio B.V., Ella Biotech GmbH, Baseclick GmbH, Geno Technology Inc., Enzo Biochem Inc., LGC Biosearch Technologies, Integrated DNA Technologies (IDT) |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |